4A Biotech
苏州四正柏
4A Biotech
Biotech/Healthcare
Suzhou Sizhengbai develops and manufactures flow cytometry antibodies. The company owns a fully proprietary antibody R&D and manufacturing platform centered on flow cytometry antibodies.
Latest round: Pre Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.